Assembly Biosciences (ASMB) Gains from Investment Securities (2016 - 2025)
Historic Gains from Investment Securities for Assembly Biosciences (ASMB) over the last 11 years, with Q3 2025 value amounting to $225000.0.
- Assembly Biosciences' Gains from Investment Securities changed N/A to $225000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $225000.0, marking a year-over-year decrease of 9190.36%. This contributed to the annual value of $2.0 million for FY2024, which is 1949.22% down from last year.
- Latest data reveals that Assembly Biosciences reported Gains from Investment Securities of $225000.0 as of Q3 2025.
- In the past 5 years, Assembly Biosciences' Gains from Investment Securities ranged from a high of $2.8 million in Q4 2023 and a low of -$2.8 million during Q3 2021
- Over the past 5 years, Assembly Biosciences' median Gains from Investment Securities value was -$8000.0 (recorded in 2021), while the average stood at -$46071.4.
- As far as peak fluctuations go, Assembly Biosciences' Gains from Investment Securities crashed by 205000.0% in 2022, and later skyrocketed by 38213.2% in 2023.
- Quarter analysis of 5 years shows Assembly Biosciences' Gains from Investment Securities stood at -$219000.0 in 2021, then crashed by 349.77% to -$985000.0 in 2022, then skyrocketed by 382.13% to $2.8 million in 2023, then dropped by 29.26% to $2.0 million in 2024, then crashed by 88.56% to $225000.0 in 2025.
- Its last three reported values are $225000.0 in Q3 2025, $225000.0 for Q2 2025, and $2.0 million during Q4 2024.